Today on Outsourcing-Pharma.com   Thirst for outsourcing fuelling product recalls SAFC boosts biologics Contract manufacturing news in brief Pharma industry bodies: people on the move Pfizer Japan cleaning out its closet

Related Industry News   Novo drops inhaled insulin plans in post-Exubera fallout Funding shot for cell-based vaccines JAMA article boosts Novartis meningitis jab US approval for once daily Cialis

Breaking News on Outsourcing Pharma
Daily  Tuesday 15 January 2008		Forward to a colleague

	Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here Access Full Stories Thirst for outsourcing fuelling product recalls Product recalls in the UK due to health and safety concerns have shot up to their highest level, with the rise in outsourcing to China fingerpointed for much of the blame... Read SAFC boosts biologics SAFC is still on its expansion drive, with yet another multi-million dollar investment announced this week, this time at the company's niche biologics plant in Carlsbad, California... Read Contract manufacturing news in brief AMRI, Pharmaceutics International, Celitrion and Gland Pharma have all recently generated new contract manufacturing news... Read Pharma industry bodies: people on the move Three pharmaceutical industry organisations - the ACRO, the DIA and the ISPE have all had people on the move... Read Pfizer Japan cleaning out its closet Pfizer Japan is cleaning out its closet, selling a range of its "surplus" biotech and pharmaceutical lab equipment via an online auction, a method that is slowly catching on in the country... Read
	All News Headlines for: January | December | November
	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here
	Related Industry News Novo drops inhaled insulin plans in post-Exubera fallout Mere months after Pfizer's high profile exit from the inhaled insulin market in the wake of Exubera's much publicised market failure, Novo Nordisk announced late last night that it, too, has decided to halt development... Read Funding shot for cell-based vaccines A major grant has been awarded to a UK consortium working to develop predictive manufacturing tools for cell-based cancer vaccines... Read JAMA article boosts Novartis meningitis jab Novartis has been keen to shout about data published this week in the Journal of the American Medical Association (JAMA) that backs up claims that it has developed the first vaccine to protect infants against the... Read US approval for once daily Cialis Eli Lilly's once-a-day version of its erectile dysfunction (ED) treatment Cialis (tadalafil) has finally got the go ahead from US regulators, six months after approval in the EU... Read Weekly Comment Warding off the generic attack A recent report has detailed the challenges facing the pharma industry as the generic flood gates open, with the constant advice to start planning early still apparently not heeded by a bewildering number of firms. Read Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Previous Headlines Former ICOS plant finds new home with Saltigo Chemical and intermediates firm Lanxess has announced that its subsidiary Saltigo is the proud new owner of a site in Washington in the US, formerly used by Eli Lilly subsidiary, ICOS... Read Pfizer vows to fight on after Nigeria arrests Pfizer is vowing to fight on as Nigerian court battles against its subsidiary in the country wage on over its alleged involvement in child deaths through experimentation over a decade ago... Read eclinical news in brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Medidata, UBC, Tessella and Datatrak... Read Cambrex makes Estonian API biz buy Cambrex' Swedish arm has agreed to purchase ProSyntest, an Estonian active pharmaceutical ingredients (API) research and development company... Read Teva earmarks $1bn for India plans The world's generics titan, Teva, has reportedly earmarked over $1bn to fuel an ambitious plan to broaden its presence in India... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com